Ligne de temps
Claude Roth
Chercheur(euse) Permanent(e)
03 févr. 2023
publication
Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Lire plus09 oct. 2020
21 juin 2019
publication
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
Lire plus08 oct. 2018
project
T cell immunity to dengue virus infection in transgenic mice expressing human HLA molecules
Lire plus08 oct. 2018
patent
A Zika virus chimeric polyepitope comprising non-structural proteins and its use in immunogenic composition (EP 17 306553.3)
Lire plus07 sept. 2018
publication
Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans
Lire plus01 août 2018
20 avr. 2018
23 févr. 2018
publication
Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development
Lire plus01 oct. 2015
patent
A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection (E14305984.8)
Lire plus20 févr. 2009
11 avr. 2007
04 juin 2006
01 juin 2001
01 juil. 2000
publication
Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC
Lire plus01 sept. 1998
01 déc. 1996
publication
Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2
Lire plus01 août 1996
publication
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
Lire plus01 déc. 1995
publication
Interleukin-2 and interleukin-4 display potent antitumour activity on rat medullary thyroid carcinoma cells
Lire plus18 août 1995
01 mars 1995
publication
[Genetically modified cells as vectors of local secretion of cytokines. Perspectives in antitumoral immunotherapy]
Lire plus01 janv. 1995
publication
Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2
Lire plus01 sept. 1994
publication
Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule
Lire plus01 janv. 1994
01 août 1993
publication
Identification of T cell peptides from C gamma 2ab involved in IgG2ab T cell-induced allotypic suppression. Relationship with the MHC haplotype of the suppressor T cell-donor Igha mice
Lire plus01 déc. 1992
publication
Inhibition of tumor growth by histoincompatible cells expressing interleukin-2
Lire plus01 janv. 1992
publication
[Inhibition of the tumoral growth induced by the injection of histo-incompatible cells producing interleukin-2]
Lire plus01 janv. 1992
publication
[Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2]
Lire plus01 janv. 1992
01 nov. 1990
01 nov. 1988
publication
IL-4, but not IL-5, can act synergistically with B cell activating factor (BCAF) to induce proliferation of resting B cells
Lire plus01 août 1988
publication
Allogeneic manipulation of the GAT idiotypic cascade. Immunization of C57BL/6 mice by BALB/c anti-idiotypes stimulates similar strain-specific V genes as the original antigen
Lire plus01 avr. 1988
publication
Biochemical characterization and biological effects of partially purified B cell-activating factor (BCAF)
Lire plus01 janv. 1986
01 juil. 1985
publication
Gene repertoire of the anti-poly(Glu60Ala30Tyr10) (GAT) immune response: comparison of VH, V kappa, and D regions used by anti-GAT antibodies and monoclonal antibodies produced after anti-idiotypic immunization
Lire plus01 juin 1985
publication
Immune response against poly(Glu60,Ala30,Tyr10) (GAT): immunization with monoclonal anti-idiotypic antibodies leads to the predominant stimulation of idiotypically similar immunoglobulins with anti-GAT activity
Lire plus01 avr. 1985
publication
Induction by monoclonal anti-idiotypic antibodies of an anti-poly(Glu60 Ala30 Tyr10) (GAT) immune response in GAT-responder and GAT-nonresponder mice
Lire plus01 mars 1985
publication
Characterization of monoclonal antibodies against prostaglandin E2: fine specificity and neutralization of biological effects
Lire plus01 janv. 1985
publication
The internal image and the structural idiotypic network (Ab1, Ab2, Ab3) in the GAT system
Lire plus01 juin 1984
publication
Poly(Glu60,Ala30,Tyr10) (GAT)-specific T cells do not express B cell public idiotopes but can be primed by monoclonal anti-idiotypic antibodies
Lire plus01 janv. 1984
publication
Public idiotopes and/or internal images in the anti-poly(Glu60Ala30Tyr10) response: analysis by monoclonal antibodies
Lire plus01 janv. 1984
publication
The use of monoclonal anti-idiotypic antibodies for studying antigen-specific T and B cell receptors
Lire plus01 déc. 1983
publication